The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -19.18%. However, over the past six months, we’ve seen a weaker performance of 6.70%. The price of CLPT fallen by 7.71% over the last 30 days. And in the last five days, it has fallen by -6.47%.
ClearPoint Neuro Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $19.22 on 02/06/25, while the lowest price for the same duration was marked at $5.11 on 07/02/24.
52-week price history of CLPT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. ClearPoint Neuro Inc’s current trading price is -35.33% away from its 52-week high, while its distance from the 52-week low is 143.25%. The stock’s price range during this period has varied between$5.11 and $19.22. The ClearPoint Neuro Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.89 million for the day, a figure considerably higher than their average daily volume of 0.26 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
ClearPoint Neuro Inc (CLPT) has experienced a quarterly decline of -31.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 351.33M and boasts a workforce of 115 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.72, with a change in price of -3.91. Similarly, ClearPoint Neuro Inc recorded 246,985 in trading volume during the last 100 days, posting a change of -23.93%.
CLPT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CLPT stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.14.
CLPT Stock Stochastic Average
As of today, ClearPoint Neuro Inc’s raw stochastic average for the last 50 days stands at 46.03%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 26.70%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 49.96% and 59.96%, respectively.
